Stem Cell Sciences receives DTI funding
Tuesday, 01 February, 2005
A consortium led by Stem Cell Sciences' UK centre has been awarded £1.2 million by the UK Department of Trade and Industry (DTI) to fund a program in drug discovery for regenerative medicine.
The consortium, which comprises Stem Cell Sciences, the Institute for Stem Cell Research at the University of Edinburgh, University College London Biochemical Engineering, GE Biosciences, Global Research Centre and the Insight Faraday Partnership, plans to develop high throughput cell screening using high density arrays of specific cell types derived from embryonic stem cells, which will be used to speed the discovery of drug based regenerative medicines.
The grant was one of three awarded to consortia of academic and industry groups in the bioprocessing sector, a key business area for funding under the DTI's Technology Programme, which aims to speed the translation of collaborative research into successful businesses.
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...
Newborns have elevated levels of an Alzheimer's biomarker
What do the brains of newborns and patients with Alzheimer's disease have in common? Both...
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
